Bone Health Technologies, Inc.
Develops a prescription wearable medical device and companion digital tools that deliver targeted mechanical stimulation to reduce bone density and strength loss in postmenopausal women with osteopenia. Clinical evidence from a randomized, double-blind, sham-controlled trial supported FDA De Novo clearance; the device is distributed by prescription in the United States with companion patient and provider resources.
Industries
Nr. of Employees
small (1-50)
Bone Health Technologies, Inc.
Patents
Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis
US-12232993-B1
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis
US-12016790-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis
US-11806262-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
US-11219542-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
US-11026824-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
US-10206802-B2
View Details
Wearable apparatus for the treatment or prevention of osteopenia and osteoporosis
US-12232993-B1
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis
US-12016790-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis
US-11806262-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
US-11219542-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
US-11026824-B2
View DetailsWearable apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis
US-10206802-B2
View DetailsProducts
Prescription wearable mechanical-stimulation device
A prescription wearable belt device that delivers targeted low-amplitude, high-frequency mechanical stimulation to the sacrum/hips and lumbar spine for daily 30-minute sessions to reduce bone density and strength loss in postmenopausal women with osteopenia.
Prescription wearable mechanical-stimulation device
A prescription wearable belt device that delivers targeted low-amplitude, high-frequency mechanical stimulation to the sacrum/hips and lumbar spine for daily 30-minute sessions to reduce bone density and strength loss in postmenopausal women with osteopenia.
Services
Online prescription issuance via a telehealth partner to enable access to the prescription-only device without an in-person visit.
Prescription-based shipping and customer technical support, including troubleshooting, returns, size exchanges prior to shipment, and a limited warranty.
Digital exercise routines and educational content bundled with the device to support strength, balance, fall prevention, and adherence; includes progress tracking and milestones within the mobile app.
Provides prescribing tools, clinical white papers, recorded physician webinars, and a clinician affiliate/referral program to support integration into clinical practice.
Online prescription issuance via a telehealth partner to enable access to the prescription-only device without an in-person visit.
Prescription-based shipping and customer technical support, including troubleshooting, returns, size exchanges prior to shipment, and a limited warranty.
Digital exercise routines and educational content bundled with the device to support strength, balance, fall prevention, and adherence; includes progress tracking and milestones within the mobile app.
Provides prescribing tools, clinical white papers, recorded physician webinars, and a clinician affiliate/referral program to support integration into clinical practice.
Expertise Areas
- Wearable medical device development and human-factors design
- Randomized, double-blind, sham-controlled clinical trial design and execution
- Imaging-based biomechanical endpoint analysis (CT/DXA + finite-element modeling)
- Regulatory strategy for novel medical devices (FDA De Novo and Breakthrough pathways)
Key Technologies
- Low-amplitude, high-frequency mechanical stimulation (sinusoidal vibration)
- On-device force/pressure sensing and accelerometer-based vibration measurement
- Automated on-board calibration algorithms for therapeutic dose delivery
- Finite-element biomechanical modeling of CT scans
News & Updates
Clinical data and company presentations at meetings including ASBMR, ENDO, ACSM, ViVE, Device Talks East, and other industry events.
Coverage in national and regional outlets detailing the FDA-cleared wearable therapy, manufacturing location, and clinical results.
Published randomized, double-blind, sham-controlled clinical trial results in a peer-reviewed journal supporting the device's efficacy endpoints.
Regulatory clearance via FDA De Novo pathway and Breakthrough Device designation for a prescription wearable therapy for low bone density.
Multiple recognitions including winning seed-stage and people’s choice awards at a women's health tech event and awards in wearable technology competitions.
Included in TIME's Best Inventions list (2025).
Clinical data and company presentations at meetings including ASBMR, ENDO, ACSM, ViVE, Device Talks East, and other industry events.
Coverage in national and regional outlets detailing the FDA-cleared wearable therapy, manufacturing location, and clinical results.
Published randomized, double-blind, sham-controlled clinical trial results in a peer-reviewed journal supporting the device's efficacy endpoints.
Regulatory clearance via FDA De Novo pathway and Breakthrough Device designation for a prescription wearable therapy for low bone density.
Multiple recognitions including winning seed-stage and people’s choice awards at a women's health tech event and awards in wearable technology competitions.
Included in TIME's Best Inventions list (2025).